Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study of Stargardt disease SAN DIEGO, Sept. 01, 2024 (Korea Bizwire) – Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel [...]
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 31, 2024 (Korea Bizwire) – A correction has been issued for the release disseminated on August 29th. Sten Vermund’s full title was corrected to Sten Vermund, MD, PhD, GVN President and Professor of Yale University, USA. The complete [...]
SHANGHAI, Aug. 30, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2024 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2024, the total revenue of Junshi [...]
ROCHESTER, N.Y., Aug. 29, 2024 (Korea Bizwire) – Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its second quarter ending August 31, 2024, on Thursday, October 3, 2024, before the open of the U.S. markets. A conference call to discuss the financial results and outlook will [...]
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 29, 2024 (Korea Bizwire) – To mitigate the mpox outbreak, the Global Virus Network (GVN) is leading a panel of experts to develop guidelines and streamline testing standards, including strengthening infrastructure to sequencing and early detection. On August 22, [...]
BASEL, Switzerland, Aug. 29, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSHRC) successfully concluded its participation in the Association for Medical Education in Europe (AMEE) 2024 Conference, which commenced last Monday in Basel, Switzerland. The three-day event provided a platform for KFSHRC to showcase its expertise in employing the latest technologies [...]
RIYADH, Saudi Arabia, Aug. 28, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSHRC) reaffirms its commitment to inclusivity and diversity in medical education, establishing itself as a leader in creating a learning environment that mirrors the global nature of modern healthcare. Housing professionals from over 77 nationalities, KFSHRC cultivates a vibrant [...]
ADELAIDE, Australia and WAKE FOREST, N.C., Aug. 27, 2024 (Korea Bizwire) – Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence. Avance Clinical CEO Yvonne Lungershausen thanked Frost & Sullivan for the global award [...]
Data from the phase Ib Beamion LUNG-1 trial selected for late-breaking oral presentation in the Presidential Symposium at WCLC on Monday, September 9. The U.S. FDA and China’s CDE have granted zongertinib Breakthrough Therapy Designation for patients with HER2-mutated NSCLC and who have received prior systemic therapy. Phase I trial data of a novel DLL3-targeting [...]
RIYADH, Saudi Arabia, Aug. 27, 2024 (Korea Bizwire) – In alignment with Saudi Arabia’s Vision 2030 healthcare goals, King Faisal Specialist Hospital & Research Centre (KFSHRC) leads in healthcare innovation with pioneering programs that train future leaders and positively impact the Saudi community. KFSHRC’s Education and Training department ensures the institution’s educational programs maintain high [...]